Triple
T391443
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Johnson & Johnson |
E8888
|
entity |
| Predicate | covid19VaccineBrand |
P1500
|
FINISHED |
| Object |
Janssen COVID-19 Vaccine
The Janssen COVID-19 Vaccine is a single-dose, viral vector-based coronavirus vaccine developed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, for the prevention of COVID-19.
|
E49854
|
NE FINISHED |
How this triple was built (5 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Janssen COVID-19 Vaccine | Statement: [Johnson & Johnson, covid19VaccineBrand, Janssen COVID-19 Vaccine]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Janssen COVID-19 Vaccine Context triple: [Johnson & Johnson, covid19VaccineBrand, Janssen COVID-19 Vaccine]
-
A.
Leqembi
Leqembi is an Alzheimer’s disease drug (lecanemab) that targets amyloid-beta plaques to slow cognitive decline in early-stage patients.
-
B.
Vaccine Education Center
The Vaccine Education Center is a program at the Children's Hospital of Philadelphia that provides evidence-based information to the public about vaccines, vaccine safety, and immunization practices.
-
C.
Vumerity
Vumerity is an oral prescription medication used to treat relapsing forms of multiple sclerosis in adults.
-
D.
Aduhelm
Aduhelm is an Alzheimer’s disease drug developed by Biogen that targets amyloid-beta plaques in the brain.
-
E.
Roche
Roche is a major Swiss multinational healthcare company and one of the world’s leading pharmaceutical and diagnostics firms.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Janssen COVID-19 Vaccine Triple: [Johnson & Johnson, covid19VaccineBrand, Janssen COVID-19 Vaccine]
Generated description
The Janssen COVID-19 Vaccine is a single-dose, viral vector-based coronavirus vaccine developed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, for the prevention of COVID-19.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Janssen COVID-19 Vaccine Target entity description: The Janssen COVID-19 Vaccine is a single-dose, viral vector-based coronavirus vaccine developed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, for the prevention of COVID-19.
-
A.
Leqembi
Leqembi is an Alzheimer’s disease drug (lecanemab) that targets amyloid-beta plaques to slow cognitive decline in early-stage patients.
-
B.
Vaccine Education Center
The Vaccine Education Center is a program at the Children's Hospital of Philadelphia that provides evidence-based information to the public about vaccines, vaccine safety, and immunization practices.
-
C.
Vumerity
Vumerity is an oral prescription medication used to treat relapsing forms of multiple sclerosis in adults.
-
D.
Aduhelm
Aduhelm is an Alzheimer’s disease drug developed by Biogen that targets amyloid-beta plaques in the brain.
-
E.
Roche
Roche is a major Swiss multinational healthcare company and one of the world’s leading pharmaceutical and diagnostics firms.
- F. None of above. chosen
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: covid19VaccineBrand Context triple: [Johnson & Johnson, covid19VaccineBrand, Janssen COVID-19 Vaccine]
-
A.
parentBrand
Indicates that one brand is the overarching or owning brand from which another brand is derived or subordinated.
-
B.
manufacturedBy
Indicates that an item or product is produced or created by a specific manufacturer or maker.
-
C.
formulatedIn
Indicates that something was created, developed, or expressed within a particular context, place, or framework.
-
D.
formerBrand
Indicates that an entity was previously used or recognized as a brand for another entity but is no longer its current brand.
-
E.
brand
chosen
Indicates that one entity is the commercial brand or label under which another entity (such as a product, service, or organization) is marketed or identified.
- F. None of above.
Provenance (6 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69a2e7f55c60819097aff65ea2ca2832 |
completed | Feb. 28, 2026, 1:04 p.m. |
| NER | Named-entity recognition | batch_69a2ec5d73e881909101308a583c8f13 |
completed | Feb. 28, 2026, 1:23 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69a405f74cd08190a2e165506638607c |
completed | March 1, 2026, 9:25 a.m. |
| NEDg | Description generation | batch_69a406a17fdc8190a067217b806fbc57 |
completed | March 1, 2026, 9:28 a.m. |
| NED2 | Entity disambiguation (via description) | batch_69a4070050dc81909fdfbcfce23e428e |
completed | March 1, 2026, 9:29 a.m. |
| PD | Predicate disambiguation | batch_69a2e96a8ca48190abbd8de9b02c115c |
completed | Feb. 28, 2026, 1:11 p.m. |
Created at: Feb. 28, 2026, 1:08 p.m.